Sr MSL, Lymphoma (Lacutamab)

Sobi•Miami, IL

3d•Remote

About The Position

Sobi is hiring three Senior Medical Science Liaisons for its lymphoma (lacutamab) work. This is a remote, field-based role supporting an assigned U.S. geography. The Senior MSL serves as a scientific expert on cutaneous T-cell lymphoma (CTCL) and lacutamab, a humanized monoclonal antibody immunotherapy targeting KIR3DL2. The role builds trusted scientific relationships, exchanges balanced medical information, and generates insights to inform U.S. Medical Affairs strategy and launch readiness. It supports Sobi’s rare disease hematology portfolio and serves as a scientific resource to hematology-oncology, dermatology, and dermato-oncology communities. As part of Hematology Medical Affairs, the role executes field activities and contributes field perspectives to the CTCL medical strategy, which is led by Medical Affairs leadership. The MSL engages academic, community, and multidisciplinary care teams while complying with regulatory, legal, and company requirements. Responsibilities include scientific exchange, insight generation, territory planning, education and congress support, clinical development and evidence-generation support, and cross-functional collaboration. The position requires frequent domestic travel by ground or air (60% or more), depending on territory size, stakeholder needs, congress participation, and business requirements. Candidates may work remotely anywhere in the continental U.S.; proximity within 30–40 minutes of a major airport is strongly preferred. Occasional evening or weekend programs may be required based on business needs.

Requirements

Accredited doctorate degree in a life-science, health-science, or basic-science discipline, such as PharmD, PhD, DNP, DSc, MD, or DO; candidates with another advanced health degree and extensive relevant industry or clinical experience may be considered.
At least 5 years of MSL experience in hematology/oncology, heme-onc, or a closely related therapeutic area.
Strong ability to understand, critically evaluate, and clearly communicate complex scientific and clinical information.
Strong commitment to patient needs and advancing scientific understanding within the CTCL community.
Ability to travel frequently domestically by ground and/or air (60% or more).
Ability to attend local, regional, and national meetings, including occasional evening or weekend programs as business needs require.
Ability to work effectively from a remote office and manage a geographically dispersed territory.

Nice To Haves

Experience in clinical practice, CTCL, peripheral T-cell lymphoma (PTCL), lymphoma, dermatology, or dermato-oncology.
Rare disease and/or product launch experience.
Clinical hematology-oncology background.
Knowledge of CTCL and/or PTCL and the multidisciplinary care environment.

Responsibilities

Serve as the primary field-based scientific point of contact for Sobi Medical Affairs within the assigned geography.
Develop and maintain two-way scientific relationships with opinion leaders, healthcare professionals, medical organizations, investigators, and other CTCL stakeholders.
Exchange accurate, fair, balanced, and scientifically rigorous information on CTCL, lacutamab, clinical data, disease biology, treatment approaches, and the care landscape.
Engage academic, community, hematology-oncology, dermatology, and dermato-oncology settings.
Respond to unsolicited scientific inquiries and connect stakeholders with Sobi resources in accordance with policies and procedures.
Identify, document, and share field insights on unmet needs, clinical practice, patient pathways, evidence gaps, stakeholder perspectives, competitive developments, and the treatment landscape.
Work with Medical Affairs leadership and cross-functional colleagues to interpret insights and inform medical strategy, tactics, educational priorities, and engagement plans.
Execute territory-level medical plans aligned with the U.S. CTCL and lacutamab medical strategy, adapting engagement to local and regional needs.
Support institution and stakeholder engagement planning.
Contribute to lacutamab launch preparedness through disease-state education, articulation of unmet need, scientific exchange, stakeholder mapping, and approved medical tactics.
Provide internal and external scientific training on CTCL disease biology, preclinical science, clinical data, evidence gaps, and relevant outcomes.
Participate in or support advisory boards, medical roundtables, webinars, symposia, and other educational activities.
Represent Sobi Medical Affairs at scientific and medical congresses and communicate key updates and implications to internal stakeholders.
Collaborate on identifying and developing field resources and scientific materials specific to CTCL and lacutamab.
Support Clinical Development and Clinical Operations with site identification and recommendations, investigator engagement, communication facilitation, site initiation, and patient accrual.
Identify evidence gaps and potential research opportunities and communicate them to internal partners.
Contribute field perspectives to evidence-generation activities, real-world evidence initiatives, publications, and medical education programs, as appropriate.
Support investigator-sponsored research and other research collaborations in accordance with company processes and governance.
Partner with Medical Affairs, Medical Information, Clinical Development, Market Access, Patient Advocacy, Commercial, Legal, Compliance, and other functions while maintaining Medical Affairs independence and integrity.
Serve as a scientific resource to internal stakeholders and contribute to cross-functional initiatives consistent with Medical Affairs objectives and company guidelines.
Manage territory planning, stakeholder prioritization, documentation, follow-through, projects, and competing priorities.
Share best practices, support colleagues, and contribute to a collaborative, respectful, patient-focused Field Medical organization.